Mithra Pharmaceuticals (XBRU:MITRA) Short-Term Debt : €20.77 Mil (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Short-Term Debt?

Mithra Pharmaceuticals's Short-Term Debt for the quarter that ended in Jun. 2023 was €20.77 Mil.

Mithra Pharmaceuticals's quarterly Short-Term Debt declined from Jun. 2022 (€48.32 Mil) to Dec. 2022 (€47.23 Mil) and declined from Dec. 2022 (€47.23 Mil) to Jun. 2023 (€20.77 Mil).

Mithra Pharmaceuticals's annual Short-Term Debt increased from Dec. 2020 (€11.48 Mil) to Dec. 2021 (€46.57 Mil) and increased from Dec. 2021 (€46.57 Mil) to Dec. 2022 (€47.23 Mil).

Mithra Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Mithra Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Short-Term Debt Chart

Mithra Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Debt

Get a 7-Day Free Trial

10.44

6.53

11.48

46.57

47.23

Mithra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Short-Term Debt	Get a 7-Day Free Trial															11.25	46.57	48.32	47.23	20.77

Mithra Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Mithra Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Mithra Pharmaceuticals (XBRU:MITRA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (XBRU:MITRA) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

0R91:UK 1TM:Germany

Address

Rue Saint-Georges 5, Liege, BEL, 4000

Website

https://www.mithra.com

Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (XBRU:MITRA) Headlines

No Headlines